European Archives - Page 335 of 1157 - European Medical Journal

Elevated Cardiovascular Disease Risk in Patients with Hidradenitis Suppurativa

Patients with hidradenitis suppurativa have an increased likelihood of developing cardiovascular disease, according to a study evaluating the association between HS and CVD

Higher Rates of Post-Inflammatory Hyperpigmentation in Patients with Skin of Colour

According to a recent retrospective study, patients with skin of colour have higher rates of post-inflammatory hyperpigmentation following Mohs micrographic surgery

Gastrointestinal Bleeding in Patients with Chronic Kidney Disease

A recent analysis provides insights into gastrointestinal bleeding among patients with chronic kidney disease.

Novel Tool to Predict Kidney Injury from Chemotherapy

A risk prediction model for kidney injury in patients with cancer receiving chemotherapy has been developed.

A doctor conducting hypnotherapy with a patient

Hypnosis: A Magical Tool in Clinical Scenarios – Part 1

This episode explores the use of hypnosis in clinical practice and its impact managing side effects.

Blood Test Predicts Knee Osteoarthritis 8 Years Earlier

A new blood test has successfully predicted risk of knee osteoarthritis eight years before signs of the disease appeared on X-rays.

Connection Between Arthritis and Blood Cancer Mutations

Researches have found a link between rheumatoid arthritis and certain gene mutations found in cancer.

Artificial Intelligence Identifies Small Renal Tumours with Radiologist Precision

A deep learning algorithm based on contrast-enhanced multiphase CT has performed well in identifying small benign renal lesions, according to new research.

Enlarged Lymph Nodes on Mammograms: A New Risk Indicator

Fat-enlarged axillary lymph nodes have been linked to significantly higher risks of type 2 diabetes, cardiovascular disease, and hypertension, according to new research.

FDA nod for Roche and Amgen’s blood testing device

The FDA has granted Breakthrough Device Designation to Roche’s new blood test, developed in collaboration with Amgen, that measures key blood markers of inherited cardiovascular risk.